Quoin Pharmaceuticals, Ltd.(QNRX)
Biotechnology
Rare Disease / Orphan Drug
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-10-15 | LANGER DENNIS Director | Purchase | +75,760 | +2848.12%78,420 | $1.70 | $128,640 | View SEC filing | |
| 2024-12-27 | Carter Denise P. Chief Operating Officer | Purchase | +1,666,668 | +3539.17%1,713,760 | $0.15 | $250,000 | View SEC filing | |
| 2024-12-27 | Myers Michael Chief Executive Officer | Purchase | +1,666,668 | +3527.19%1,713,920 | $0.15 | $250,000 | View SEC filing | |
| 2024-12-27 | Dunn Gordon Chief Financial Officer | Purchase | +366,663 | +1270.66%395,519 | $0.15 | $54,999 | View SEC filing | |
| 2024-12-27 | Culverwell Anthony James Director | Purchase | +300,000 | +94637.22%300,317 | $0.15 | $45,000 | View SEC filing | |
| 2024-09-11 | Dunn Gordon Chief Financial Officer | Purchase | +28,856 | +100.00%28,856 | $0.80 | $23,205 | View SEC filing | |
| 2024-09-05 | Carter Denise P. Chief Operating Officer | Purchase | +37,735 | +403.28%47,092 | $0.76 | $28,737 | View SEC filing | |
| 2024-09-05 | Myers Michael Chief Executive Officer | Purchase | +37,894 | +404.94%47,252 | $0.76 | $28,916 | View SEC filing | |
| 2024-06-10 | LANGER DENNIS Director | Sale | -297 | -84.86%53 | $0.73 | $217 | View SEC filing |
1-9 of 9